Rahul Banerjee, MD, FACP

Dr. Rahul Banerjee, MD, FACP, (Twitter/X: @RahulBanerjeeMD) is an Assistant Professor at the Fred Hutchinson Cancer Center and at the University of Washington in Seattle, WA. His clinical interests are in multiple myeloma and CAR-T therapy. He is a member of the International Myeloma Working Group and has published over 100 peer-reviewed publications with an emphasis on improving the experiences of patients as they undergo treatment for multiple myeloma.
Financial relationships
-
Attribution:SelfType of financial relationship:Independent contractorIneligible company:Adaptive BiotechTopic:ConsultingDate added:10/13/2022Date updated:08/19/2025
-
Attribution:SelfType of financial relationship:Independent contractorIneligible company:BMSTopic:ConsultingDate added:10/13/2022Date updated:08/19/2025
-
Attribution:SelfType of financial relationship:Independent contractorIneligible company:Caribou BiosciencesTopic:ConsultingDate added:10/13/2022Date updated:08/19/2025
-
Attribution:SelfType of financial relationship:Independent contractorIneligible company:Genentech/RocheTopic:ConsultingDate added:10/13/2022Date updated:08/19/2025
-
Attribution:SelfType of financial relationship:Independent contractorIneligible company:GSKTopic:ConsultingDate added:10/13/2022Date updated:08/19/2025
-
Attribution:SelfType of financial relationship:Independent contractorIneligible company:KaryopharmTopic:ConsultingDate added:10/13/2022Date updated:08/19/2025
-
Attribution:SelfType of financial relationship:Independent contractorIneligible company:Legend BiotechTopic:ConsultingDate added:10/13/2022Date updated:08/19/2025
-
Attribution:SelfType of financial relationship:Independent contractorIneligible company:JNJ / JanssenTopic:ConsultingDate added:10/13/2022Date updated:08/19/2025
-
Attribution:SelfType of financial relationship:Independent contractorIneligible company:PfizerTopic:ConsultingDate added:10/13/2022Date updated:08/19/2025
-
Attribution:SelfType of financial relationship:Independent contractorIneligible company:SanofiTopic:ConsultingDate added:10/13/2022Date updated:08/19/2025